Belgian molecular diagnostics company Biocartis Group NV has raised €55m and will use the funds mainly to...
Up To Date
Latest News
Europe’s first gene therapy company has floated on Euronext: Gensight raised €40m in its IPO. And it is not...
When NASA blasted off to the International Space Station on Monday morning, it had UK tech on board. A...
Cell Medica has acquired Swiss antibody specialist Delenex Therapeutics. The deal nets the British cellular...
Vienna-based vaccine specialist Themis Bioscience GmbH has secured broad access to a promising virus vaccine...
Californian biopharma Medivation has agreed to confidential negotiations with its suitors, in particular the...